How is information collected for Health Canada regarding adverse drug reactions after administration of a new drug on the market?

Question

Quizplus · Accepted Answer

The Canadian Adverse Drug Reaction Monitoring Program (CADRMP) is responsible for the collection and evaluation of spontaneous reports of adverse drug reactions (ADRs) associated with marketed health products in Canada. Health care providers and consumers are encouraged to voluntarily report any suspected ADRs to the CADRMP. This data is then used by Health Canada to monitor the safety of drugs on the market and take appropriate actions if necessary.

How Is Information Collected for Health Canada Regarding Adverse Drug